1. An insight towards anticancer potential of major coffee constituents
    Nasimudeen R. Jabir et al, 2018, BioFactors CrossRef
  2. Autophagy-dependent cell death – where, how and why a cell eats itself to death
    Shani Bialik et al, 2018, J Cell Sci CrossRef
  3. TEEG Induced A549 Cell Autophagy by Regulating the PI3K/AKT/mTOR Signaling Pathway
    Lu Shi et al, 2019, Analytical Cellular Pathology CrossRef
  4. null
    Hai Zhang et al, 2019 CrossRef
  5. Investigational serine/threonine kinase inhibitors against prostate cancer metastases
    Claudio Festuccia, 2017, Expert Opinion on Investigational Drugs CrossRef
  6. Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition
    Lei Shao et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  7. IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway.
    Ting-Ting Li et al, 0 CrossRef
  8. Microtubule-targeting agents and their impact on cancer treatment
    Vladimír Čermák et al, 2020, European Journal of Cell Biology CrossRef
  9. Antitumor Activity of Cabazitaxel and MSC-TRAIL Derived Extracellular Vesicles in Drug-Resistant Oral Squamous Cell Carcinoma.
    Yongle Qiu et al, 2020, Cancer Manag Res CrossRef
  10. B and T lymphocyte attenuator regulates autophagy in mycobacterial infection via the AKT/mTOR signal pathway
    Jiao Liu et al, 2021, International Immunopharmacology CrossRef
  11. The Sonic Hedgehog signaling pathway regulates autophagy and migration in ovarian cancer.
    Yibin Pan et al, 2021, Cancer Med CrossRef
  12. Efficient delivery of hydrophobic drug, Cabazitaxel, using Nanodisc: A Nano sized free standing planar lipid bilayer
    Abhishek Kumar Pandey et al, 2021, Journal of Molecular Liquids CrossRef
  13. Akt inhibition improves the efficacy of cabazitaxel nanomedicine in preclinical taxane-resistant cancer models
    Tongyu Li et al, 2021, International Journal of Pharmaceutics CrossRef
  14. Astragaloside IV enhances the sensibility of lung adenocarcinoma cells to bevacizumab by inhibiting autophagy.
    Liang Li et al, 2022, Drug Dev Res CrossRef
  15. Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway.
    Wen Zhang et al, 2021, FEBS Open Bio CrossRef
  16. Qing Yan Li Ge Tang, a Chinese Herbal Formula, Induces Autophagic Cell Death through the PI3K/Akt/mTOR Pathway in Nasopharyngeal Carcinoma Cells In Vitro
    Ching-Huey Yang et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  17. Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
    Linda Wordeman et al, 2021, Cancers CrossRef
  18. Targeting PI3K/Akt signal transduction for cancer therapy
    Yan He et al, 2021, Sig Transduct Target Ther CrossRef
  19. Fabrication of chitosan/PVP/dihydroquercetin nanocomposite film for in vitro and in vivo evaluation of wound healing
    Jinping Zhang et al, 2022, International Journal of Biological Macromolecules CrossRef
  20. F-box protein FBXO41 plays vital role in arsenic trioxide-mediated autophagic death of cancer cells
    Yashika Agrawal et al, 2022, Toxicology and Applied Pharmacology CrossRef
  21. Enhancing autophagy in Alzheimer's disease through drug repositioning
    Mehdi Eshraghi et al, 2022, Pharmacology & Therapeutics CrossRef
  22. Interlaboratory evaluation of a digital holographic microscopy–based assay for label-free in vitro cytotoxicity testing of polymeric nanocarriers
    Anne Marzi et al, 2022, Drug Deliv. and Transl. Res. CrossRef
  23. New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways
    Alma Martelli et al, 2022, Cancers CrossRef
  24. Extracellular Vesicle-Based Drug Delivery Systems for Head and Neck Squamous Cell Carcinoma: A Systematic Review
    Karolina Dżaman et al, 2023, Pharmaceutics CrossRef
  25. Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel
    Mário Sousa-Pimenta et al, 2023, Front. Pharmacol. CrossRef
  26. TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication
    Sara Iachettini et al, 2024, J Exp Clin Cancer Res CrossRef